<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00864825</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-09-6893-MW-CTIL</org_study_id>
    <nct_id>NCT00864825</nct_id>
  </id_info>
  <brief_title>Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia</brief_title>
  <official_title>Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to evaluate the efficacy of allopurinol, compared to placebo,
      as add-on to anti-psychotics in the treatment of patients with schizophrenia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An emerging body of evidence supports a purinergic hypothesis for schizophrenia. Adenosine
      agonists have been shown to have properties similar to those of dopamine antagonists and
      there is a well characterized antagonistic interaction between adenosine and dopamine
      receptors in the ventral striatum1. Increased adenosinergic transmission has been
      demonstrated to reduce the affinity of dopamine agonists for dopamine receptors. It has been
      theorized that adenosine may exert some of its antipsychotic effects through modulation of
      glutamatergic transmission.

      Three double-blind, randomized, placebo-controlled trials have showed statistically
      significant greater improvements in PANSS scores in the allopurinol groups vs. placebo
      groups. These empiric data, together with the theoretical and basic science background cited,
      provide the impetus for this proposed study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PANSS total score.</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PANSS positive, negative and general psychopathology scales, BACS, CGI, Simpson-Angus Scale.</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">248</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Schizoaffective Disorder</condition>
  <arm_group>
    <arm_group_label>Allopurinol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Allopurinol</intervention_name>
    <description>Allopurinol 1 capsule 300 mg, or placebo, bid (twice a day) for 42 days.</description>
    <arm_group_label>Allopurinol</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Alloril, Zylol, Zyloric</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female, 18-65 years of age, inclusive

          2. Because gout is relatively rare in women of childbearing age, there are few reports
             describing the use of allopurinol during pregnancy; in those there were no adverse
             fetal outcomes attributable to allopurinol. Therefore, only females who are abstinent
             or practicing an established method of birth control (oral contraceptive tablets,
             hormonal implant device, hormone patch, injectable contraceptive, intrauterine device
             [IUD]) can be included in the trial.

          3. Willing and able to provide informed consent, after the nature of the study has been
             fully explained

          4. Current DSM-IV-TR diagnosis of schizophrenia as confirmed by SCID

          5. Symptoms: 4 (moderate) or above on CGI-S AND &gt;= 4 (moderate) score on two of the
             following four PANSS items: delusions, hallucinatory behaviors, conceptual
             disorganization or suspiciousness/ persecution.

          6. Must be on any antipsychotic drug for at least 2 weeks prior to the baseline visit, at
             doses within the PORT criteria. Patients receiving higher doses will have their
             records reviewed to insure that dose is required. Patients receiving two
             anti-psychotics, or IM depot antipsychotics can also be included.

          7. Inpatients or outpatients.

        Exclusion Criteria:

          1. Unwilling or unable, in the opinion of the Investigator, to comply with study
             instructions

          2. Pregnant or breast-feeding

          3. Unstable medical disease (malignancy, poorly controlled diabetes, active ischemic
             cardiac disease, or cardiomyopathy, serious pulmonary disease, , kidney disease,
             impaired liver functioning

          4. Likely allergy or sensitivity to allopurinol

          5. At significant risk of committing suicide, or in the opinion of the Investigator,
             currently is at imminent risk of suicide or harming others.

          6. Suffers from a significant Substance Dependence disorder based on DSM-IV criteria
             within the 3 months prior to Screening, or is deemed by the Investigator to have a
             high risk of substance use during the study. Patients with a history of recreational
             use of cannabinoids or alcohol, and/or patients who smoke cigarettes can be included.

          7. Concurrent delirium, mental retardation, drug-induced psychosis, or history of brain
             trauma.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Weiser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Abrabanel Mental Health Center</name>
      <address>
        <city>Bat Yam</city>
        <zip>59436</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beer-Yaakov Mental Health Center</name>
      <address>
        <city>Beer-Yaakov</city>
        <zip>70350</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shalvata Mental Health Center</name>
      <address>
        <city>Hod Hasharon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jaffa Mental House Center</name>
      <address>
        <city>Jaffa</city>
        <zip>66849</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzog Medical Center, Psychiatry</name>
      <address>
        <city>Jerusalem</city>
        <zip>91351</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kfar Shaul Mental Health Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nes Ziona Mental Health Center</name>
      <address>
        <city>Nes Ziona</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shaar Menashe Mental Health Center</name>
      <address>
        <city>Shaar Menashe</city>
        <zip>38814</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center, Psychiatry Department</name>
      <address>
        <city>Tel Hashomer, Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lev Hasharon Mental Health Center</name>
      <address>
        <city>Zur-Moshe</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Urgenta Clinica &quot;E. Pamfil&quot; Timisoara</name>
      <address>
        <city>Bd. Iosif Bulbuca, 156, jud timis</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, sectia 14</name>
      <address>
        <city>Berceni st., 10-12, Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, Clinica 9</name>
      <address>
        <city>Berceni st., 10-12, sector 4, Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, sectia 10</name>
      <address>
        <city>Berceni st., 10-12, sector 4, Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, sectia 12</name>
      <address>
        <city>Berceni st., 10-12, sector 4, Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul clinic de Psihiatrie, sectia 13</name>
      <address>
        <city>Berceni st., 10-12, sector 4, Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, sectia 1</name>
      <address>
        <city>Berceni st., 10-12, sector 4, Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, sectia 3</name>
      <address>
        <city>Berceni st., 10-12, sector 4, Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, sectia 6</name>
      <address>
        <city>Berceni st., 10-12, sector 4, Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic, sectia 8</name>
      <address>
        <city>Berceni st., sector 4 Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul de Psihiatrie, Titan</name>
      <address>
        <city>Bld Nicolae Grigorescu, no. 41, Sector 3,</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Urgenta Militar Sectia Psihiatrie Clinica</name>
      <address>
        <city>Bucuresti, Mircea Vulcanescu 88, Str. Vulcanescu, Nr. 88</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul de Neuropsihiatrie Oradea</name>
      <address>
        <city>Cuza Voda st, 36, Oradea</city>
        <zip>410097</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica de Psihiatrie nr.1</name>
      <address>
        <city>Gh. Marinescu st.38 ,Targu-Mures</city>
        <zip>540139</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean De Urgenta, Clinica Psihiatrie</name>
      <address>
        <city>Octavian Goga st, 17, Arad</city>
        <zip>310022</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie &quot;Socola&quot;</name>
      <address>
        <city>Sos Bucium, 36, Iasi</city>
        <zip>700282</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Colentina Cabinet Psihiatrie Ambulatoriu</name>
      <address>
        <city>Sos. Stefan Cel Mare Nr. 19-21, sect. 2</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie &quot;Ghe. Preda&quot;</name>
      <address>
        <city>Str. Bagdazar 12, Sibiu</city>
        <zip>550245</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta -Cluj</name>
      <address>
        <city>Str. Clinicilor nr. 3-5, 3400</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul de Psihiatrie Botosani</name>
      <address>
        <city>Str. I.C.Bratianu Nr. 116, Botosani</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie si Neurologie</name>
      <address>
        <city>Str. Prundului 7 - 9, Brasov</city>
        <zip>500123</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean, Sectia Clinica Psihiatrie</name>
      <address>
        <city>Str. Victor Babes, nr. 43, Cluj Napoca</city>
        <zip>400012</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul de Psihiatrie si Neurologie</name>
      <address>
        <city>Str.Mihai Eminescu, Nr.18, Brasov</city>
        <zip>500079</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>Romania</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2009</study_first_submitted>
  <study_first_submitted_qc>March 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2009</study_first_posted>
  <last_update_submitted>May 6, 2012</last_update_submitted>
  <last_update_submitted_qc>May 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Schizophrenia</keyword>
  <keyword>Allopurinol</keyword>
  <keyword>Add-on-treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antipsychotic Agents</mesh_term>
    <mesh_term>Allopurinol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

